The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The In Vivo Toxicology Market Compare Between 2026 And 2030?
The in vivo toxicology market has experienced substantial expansion in recent years. This market is projected to grow from $5.61 billion in 2025 to $6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the limited availability of standardized animal models, reliance on manual laboratory procedures, increasing pharmaceutical R&D activities, the rising prevalence of chronic disease studies, and the adoption of basic imaging and analytical instruments.
The in vivo toxicology market size is anticipated to show significant expansion in the coming years, with its value expected to reach $7.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This projected growth during the forecast period is driven by factors such as the development of genetically modified organisms for targeted research, the integration of automated and high-throughput screening systems, an increase in CRO outsourcing for toxicology testing, advancements in in vivo imaging and monitoring technologies, and a rising focus on alternative models and the reduction of animal testing. Major trends foreseen for the forecast period include the increasing adoption of rodent and non-human primate models, a growing demand for advanced toxicology assay kits and reagents, the expansion of immunotoxicity and genotoxicity testing services, increased utilization of automated liquid handling and imaging systems, and enhanced regulatory compliance and ethical standards in animal testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp
What Primary Drivers Are Shaping The In Vivo Toxicology Market?
The in vivo toxicology market is projected to expand due to the rising volume of drug discoveries. This process entails the scientific identification and design of novel compounds intended for disease treatment or prevention. Advances in biotechnology have greatly accelerated drug discovery by improving disease understanding and facilitating the development of more precise therapies. In drug discovery, in vivo toxicology plays a crucial role, allowing for the assessment of safety, tolerability, and possible side effects of experimental compounds within entire living organisms. It aids in pinpointing toxicities that limit dosage and guides the formulation and dosing strategies before clinical trials begin. For example, in November 2024, data from the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, indicated that more than 12,000 new medicines were undergoing clinical trials in 2023, a notable increase from approximately 9,000 in 2022. Of these, oncology comprised 33% of the development pipeline, while infectious and central nervous system diseases accounted for 13% and 12%, respectively. Consequently, the increasing volume of drug discoveries is fueling the expansion of the in vivo toxicology market.
How Are Segments Identified Within The In Vivo Toxicology Market Segment Framework?
The in vivo toxicology market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing
3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals
4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications
5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms
Subsegments:
1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents
2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems
What Market Trends Are Affecting The In Vivo Toxicology Market?
Major companies in the in vivo toxicology market are prioritizing the development of advanced solutions, including secure cloud-based real-time data platforms, to streamline study management and enhance the speed of decision-making. These platforms enable researchers and clients to securely and remotely access toxicology study data, milestones, planning tools, and documents, thereby fostering improved collaboration and transparency. For instance, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, launched Apollo, a secure cloud-based platform providing real-time access to toxicology study data. This platform is designed to support in vivo general toxicology studies with features for data visualization, planning, and milestone tracking. By offering real-time access to critical study information, it facilitates quicker and more informed decisions. The platform further assists in optimizing project planning and budget estimation throughout the drug development process, ultimately boosting precision, efficiency, and collaboration in in vivo research through the digitization of toxicology workflows.
Who Are The Companies Competing Within The In Vivo Toxicology Market?
Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.
Get The Full In Vivo Toxicology Market Report:
https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report
Which Geographic Region Dominates The In Vivo Toxicology Market?
North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In Vivo Toxicology Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report
Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company
In Vitro Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
Adme Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report
Genetic Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model